Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy and safety of coadministration AD-4833 and SYR-322 in patients with diabetes mellitus.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Takeda
NCT07590193 · Diabetes Mellitus, Type 2
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT03481829 · Diabetes Mellitus, Obesity, and more
NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus
Hirosaki-shi, Aomori
Kisaratsu-shi, Chiba
Matsuyama, Ehime
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions